MyAverix Finance MyAverix Finance

US · General

Marker Therapeutics Inc (MRKR)

Diversified

Marker Therapeutics Inc (MRKR) is listed on US in the General sector. Industry: Diversified. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for MRKR

P/E ratio
18.00

Marker Therapeutics Inc (MRKR) — FAQ

What is MRKR's P/E ratio?

The price-to-earnings (P/E) ratio for Marker Therapeutics Inc (MRKR) is 18.00 (data as of 2026-05-23).

Does Marker Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Marker Therapeutics Inc (MRKR). Check the MyAverix Finance app for the latest dividend data.

What sector is Marker Therapeutics Inc in?

Marker Therapeutics Inc (MRKR) is classified in the General sector (Diversified industry).

What exchange is MRKR listed on?

MRKR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play